To include your compound in the COVID-19 Resource Center, submit it here.

Ascendis leads latest pack of follow-ons with $600M raise

Four therapeutics companies raised nearly $1.2 billion in follow-ons after market close Tuesday, signaling sustained investor demand for biotech

Read the full 197 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE